Congenital varicella syndrome: The evidence for secondary prevention with varicella-zoster immune globulin

CMAJ. Canadian Medical Association Journal

Volumn 183, Issue 2, 2011, Pages 204-208

  Cohen, Arlan ^d   Maschopoulos, Panagis ^b   Stiehm, Richard E ^a   Koren, Gideon ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS AT EL PASO   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; HERPES ZOSTER IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AMNIOCENTESIS; ANAPHYLAXIS; ANTIBODY RESPONSE; ANTIBODY TITER; APLASIA; APNEA; BACTERIAL PNEUMONIA; CASE REPORT; CELLULAR IMMUNITY; CHICKENPOX; CLUBFOOT; CONGENITAL VARICELLA SYNDROME; DRUG HYPERSENSITIVITY; ECHOGRAPHY; FEMALE; FETUS LIVER; HUMAN; HUMORAL IMMUNITY; HYDRAMNIOS; INTRAUTERINE GROWTH RETARDATION; LATEX AGGLUTINATION TEST; MALPRACTICE; NEWBORN; OXYGEN THERAPY; REVIEW; SECONDARY PREVENTION; STOMACH FUNDOPLICATION; TRACHEOSTOMY; VARICELLA ZOSTER VIRUS; VOMITING;

EID: 79551692299     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.100615     Document Type: Review

References (22)

1. Alkalay AL, Pomerance JJ, Rimoin DI. Fetal varicella syndrome. J Pediatr 1987;111:320-3. (Pubitemid 17157498)
2. Tan MP, Koren G. Chickenpox in pregnancy: revisited. Reprod Toxicol 2006;21:410-20.
3. Enders G, Miller E, Cradock-Watson J, et al. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994;343:1548-51. (Pubitemid 24180055)
4. Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ 2003;169:207-8.
5. Enders G, Miller E. Varicella and herpes zoster in pregnancy and the newborn. In: Varicella- zoster virus: virology and clinical management. Cambridge University Press 2000; 317-47.
6. Mouly F, Mirlesse V, Meritet J, et al. Prenatal diagnosis of fetal varicella-zoster virus infection with polymerase chain reaction of amniotic fluid in 107 cases. Am J Obstet Gynecol 1997; 177: 894-8. (Pubitemid 27516064)
7. Brunell PA, Ross A, Miller H, et al. Prevention of varicella by zoster immune globulin. N Engl J Med 1969;280:1191-4.
8. Taylor-Robinson D. Chickenpox and herpez zoster. III. Tissue culture studies. Br J Exp Pathol 1959;40:521-32.
9. McGregor JA, Madinger AJ. Varicella zoster in pregnancy. In: Infection protocols for obstetrics and gynecology. Montvale (NJ): Medical Economics Publishing; 1992. p. 94-100.
10. Al-Katawee YA, Al-Hasoun YA, Taha MN, et al. Congenital varicella-zoster virus infection. A rare case of severe brain and ocular malformations without limb or cutaneous involvement in a newborn after maternal subclinical infection. Saudi Med J 2005; 26:869-71. (Pubitemid 40903360)
11. Orenstein WA, Heyman DL, Ellis RJ, et al. Prophylaxis of varicella in high risk children: response effect of zoster immune globulin. J Pediatr 1981;98:368-73. (Pubitemid 11106236)
12. Brunell PA, Gershon AA, Hughes WT, et al. Prevention of varicella in high-risk children; a collaborative study. Pediatrics 1972; 50:718-22.
13. Gershon AA, Steinberg S, Brunell PA. Zoster immune globulin: a further assessment. N Engl J Med 1974;290:243-5.
14. Paryani SG, Arvin AM, Koropchak CM, et al. Comparison of varicella zoster antibody titers in patients given intravenous immune serum globulin or varicella zoster immune globulin. Pediatr 1984;105:200-5. (Pubitemid 14060206)
15. Thoughton J, Crealey G, Crawford V, et al. VZIG administration in pregnant women exposed to chickenpox. Proceedings of the 18th European Congress of Clinical Microbiology and Infectious Diseases; 2008 Apr. 19-22; Barcelona, Spain. Abstract no. 0254. Munich: European Society of Clinical Microbiology and Infectious Diseases; 2008.
16. Rouse DJ, Gardner M, Allen SJ, et al. Management of the presumed susceptible varicella exposed gravida: a cost effectiveness/cost-benefit analysis. Obstet Gynecol 1996;87:932-6. (Pubitemid 26159387)
17. ACOG practice bulletin. Perinatal viral and parasitic infections. Number 20, Sept. 2000. (Replaces educational bulletin number 177, February 1993). American College of Obstetrics and Gynecologists. Int J Gynaecol Obstet. 2002;76:95-107
18. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR Recomm Rep 1996;45:1-36.
19. Vaccines, blood and biologics: varicella zoster immune globulin (VZIG), anticipated short supply and alternate product availability under an investigational new drug application expanded acccess protocol. Silver Spring (MD): U.S. Food and Drug Administration; 2008. Available: www .fda .gov /BiologicsBloodVaccines /SafetyAvailability/ucm176029.htm (accessed 2010 Dec. 22).
20. CDC. Varicella Zoster Immune Globulin for the prevention of chickenpox. MMWR Morb Mortal Wkly Rep 1984;33:84-90.
21. Pickering LK, Baker CJ, Kimberling DW, et al., editors. 2009 Red Book Report of the Committee on Infectious Diseases. Elk Grove Village (IL): American Academy of Pediatrics; 2009.
22. Gruslin A. Steben M, Halperin S., et al. SOGC Clinical Practice Guidelines. Immunization in pregnancy. JOGC 2009;31: 1085-1092. Available: www.sogc.org/guidelines/documents/gui236CPG0911.pdf (accessed 2010 Dec. 22).